the RJ Hamster Show
the RJ Hamster Show
the RJ Hamster Show
RJ Hamster
Log into Keith’s $5,000 AI Signals Trading system
Editor’s Note: Recently, we met with a fintech CEO. He told us about a system he created after tracking $29 billion. A website that shows you the day’s best trades, 90 minutes before they occur, by using AI on 2,467 stocks. At first, it sounded like “pie in the sky” – until we saw the results. Read on…
– Stephen Prior, Publisher
Log Into Keith’s $5,000 AI Signals Trading System
Dear Reader,
Today, we’re sharing a new AI “trade detector” for 2026.
Each morning, it shows you the most lucrative trades taking shape – 90 minutes before they occur.
See how it works – right now – on 2,467 different stocks:
Last year alone, it returned 124% in a backtest, crushing the market nearly 3-fold in a model portfolio.
We developed this system by using AI on a new “micro” level most people have never seen before. In fact, we used the same platform that helped us call last year’s crash and rally (even posting a free pick that doubled in 4 months).
I urge you to try our new system (no purchase required) by April 22… to prepare for an echo of the late 1990s set to slam stocks this month.
So far, our 2026 beta results have been remarkable…
37.7% gain in 33 days on
22% gain in 6 days on (ALB)
21.4% gain in 4 days on (DECK)
21.3% gain in 30 days on (HWM)
20.2% gain in 15 days on (SDNK)
18.3% gain in 16 days on (GRMN)
15.4% gain in 7 days on (TPR)
15.2% gain in 7 days on (EFX)
15% gain in 2 days on (DASH)
14.9% gain in 30 days on (LMT)
14.2% gain in 5 days on (TER)
14% gain in 2 days on (DDOG)
13.9% gain in 1 day on (PAYC)
13.4% gain in 6 days on (EME)
12.6% gain in 8 days on (FCX)
11.9% gain in 1 day on (ALGN)
…and dozens more
We value this new AI system at $5,000.
But today, April 17, you can claim free access here (no purchase required).
Regards,
Keith Kaplan
CEO, TradeSmith
Monument Traders Alliance, LLC
You are receiving this email because you subscribed to Trade of the Day.
Trade of the Day is published by Monument Traders Alliance, LLC.
To stop receiving special invitations and offers from Trade of the Day, please click here.
Please note: This will not impact the fulfillment of your subscription in any way.
Ready to start investing? Click here now.
Questions? Check out our FAQs. Trying to reach us? Contact us here.
To cancel by mail or for any other subscription issues, write us at:
Trade of the Day | 14 West Mount Vernon Place |Baltimore, MD 21201
North America: 800.507.1399 | International: +1.443.353.4977
Website | Privacy Policy
Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day.
© 2026 Monument Traders Alliance, LLC All Rights Reserved
Please do not reply to this email as it goes to an unmonitored inbox.
Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation.
Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.
REF: 000142349377
RJ Hamster
Log into Keith’s $5,000 AI Signals Trading system
Editor’s Note: Recently, we met with a fintech CEO. He told us about a system he created after tracking $29 billion. A website that shows you the day’s best trades, 90 minutes before they occur, by using AI on 2,467 stocks. At first, it sounded like “pie in the sky” – until we saw the results. Read on…
– Stephen Prior, Publisher
Log Into Keith’s $5,000 AI Signals Trading System
Dear Reader,
Today, we’re sharing a new AI “trade detector” for 2026.
Each morning, it shows you the most lucrative trades taking shape – 90 minutes before they occur.
See how it works – right now – on 2,467 different stocks:
Last year alone, it returned 124% in a backtest, crushing the market nearly 3-fold in a model portfolio.
We developed this system by using AI on a new “micro” level most people have never seen before. In fact, we used the same platform that helped us call last year’s crash and rally (even posting a free pick that doubled in 4 months).
I urge you to try our new system (no purchase required) by April 22… to prepare for an echo of the late 1990s set to slam stocks this month.
So far, our 2026 beta results have been remarkable…
37.7% gain in 33 days on
22% gain in 6 days on (ALB)
21.4% gain in 4 days on (DECK)
21.3% gain in 30 days on (HWM)
20.2% gain in 15 days on (SDNK)
18.3% gain in 16 days on (GRMN)
15.4% gain in 7 days on (TPR)
15.2% gain in 7 days on (EFX)
15% gain in 2 days on (DASH)
14.9% gain in 30 days on (LMT)
14.2% gain in 5 days on (TER)
14% gain in 2 days on (DDOG)
13.9% gain in 1 day on (PAYC)
13.4% gain in 6 days on (EME)
12.6% gain in 8 days on (FCX)
11.9% gain in 1 day on (ALGN)
…and dozens more
We value this new AI system at $5,000.
But today, April 17, you can claim free access here (no purchase required).
Regards,
Keith Kaplan
CEO, TradeSmith
Monument Traders Alliance, LLC
You are receiving this email because you subscribed to Trade of the Day.
Trade of the Day is published by Monument Traders Alliance, LLC.
To stop receiving special invitations and offers from Trade of the Day, please click here.
Please note: This will not impact the fulfillment of your subscription in any way.
Ready to start investing? Click here now.
Questions? Check out our FAQs. Trying to reach us? Contact us here.
To cancel by mail or for any other subscription issues, write us at:
Trade of the Day | 14 West Mount Vernon Place |Baltimore, MD 21201
North America: 800.507.1399 | International: +1.443.353.4977
Website | Privacy Policy
Keep the emails you value from falling into your spam folder. Whitelist Trade of the Day.
© 2026 Monument Traders Alliance, LLC All Rights Reserved
Please do not reply to this email as it goes to an unmonitored inbox.
Nothing published by Monument Traders Alliance should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation.
Any investments recommended by Monument Traders Alliance should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company.
Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of Monument Traders Alliance, LLC, 14 West Mount Vernon Place, Baltimore, MD 21201.
REF: 000142349377
RJ Hamster
IMSA Official Home | Race results, schedule, standings, news,…
Follow the legendary 12 Hours of Sebring on IMSA.com—get race news, schedules, live timing, results, and full coverage from the IMSA WeatherTech SportsCar Championship.
— Read on www.imsa.com/
RJ Hamster
Amazon UK Is STILL Selling Glue Traps Despite Evidence…
Forwarded this email? Subscribe here for more
Amazon UK Is STILL Selling Glue Traps Despite Evidence of Illegal Use
APR 16READ IN APP
It takes seconds. Seconds to find glue traps for sale on Amazon UK. Seconds to buy them. Seconds to scroll through the reviews and see the reality.
These products may be marketed for insects, but there is clear evidence they are being used on rodents in the UK. Within just a few listings, there are videos and images showing the truth. Mice and rats, living animals, stuck on glue traps purchased from Amazon UK. Panicking. Struggling. Suffering. This is happening in the UK, in plain sight, on listings hosted on Amazon UK’s platform.
And in much of the UK, the use of glue traps is illegal.
A rat that was sadistically named Fred before being caught and then killed in a glue trap purchased from Amazon UK less than two weeks ago.
Let’s be absolutely clear about the law:
- In England, under the Glue Traps (Offences) Act 2022, it is a criminal offence to use glue traps unless you are a licensed professional operating under strict and exceptional conditions, yet anyone and everyone can buy them from Amazon UK and use them unlawfully.
- In Wales, the law goes further. Under the Agriculture (Wales) Act 2023, glue traps are completely banned.
- In Scotland, the Wildlife Management and Muirburn (Scotland) Act 2024 will ban the use, possession and sale of rodent glue traps from 1 July 2026.
The direction of travel across the UK is unmistakable. These devices are being recognised for what they are: cruel, indiscriminate, and unacceptable. And yet Amazon UK continues to sell them freely. This highlights a clear gap between the law and what is happening in practice. This is a platform making these products easily accessible, despite evidence they are being misused.
Amazon UK is one of the UK’s largest e-commerce platforms. It has the power to restrict products by location, to enforce compliance, and to remove harmful items. Yet these products remain available without restriction.
And that choice has consequences.
Glue traps are one of the most inhumane devices still in use. Animals caught on them do not die quickly. They suffer for hours, sometimes days. They fight to escape. They tear their own skin, break their own limbs, suffocate, starve, or die from sheer exhaustion and fear.
Video taken and uploaded to Amazon UK on the 30th of January last year, after they were made illegal in England and Wales.
This is prolonged, preventable cruelty and these products continue to be sold through Amazon UK. The evidence is not hidden. It is on their own website. There are recent posts, including from late March 2026, showing live rats and mice stuck on glue traps sold through Amazon UK. And it does not stop there.
You can purchase these traps yourself, even while living in England, where their use is heavily restricted by law. There are no warning messages. No restrictions. No safeguards. It takes less than 20 seconds to complete a purchase. Whether through oversight or policy, the current system allows these products to be purchased without restriction.
Video taken and uploaded to Amazon UK on the 14th of February last year, after they were made illegal in England and Wales.
It shows, beyond doubt, that Amazon UK cannot regulate how these products are used. And yet it continues to sell them anyway.
Even the RSPCA has stepped in. On 5 April, on instagram they urged the public to report the sale and use of glue traps to the police via 101. That should be a wake up call. When a major animal welfare organisation is telling people to report a product, why is it still being sold by the UK’s largest online retailer?
This is not just a reputational issue. It raises serious legal and moral concerns. By allowing unrestricted sales, Amazon UK is actively undermining the intent of UK law and allowing the continued availability of products linked to serious animal welfare concerns.
Yet, the solution could not be simpler: Amazon UK could stop this today.
A basic postcode restriction would prevent glue traps being sold to England, Wales and Scotland. Listings could be removed from the UK platform entirely. These are standard controls. Amazon UK already has the infrastructure to do this. And glue traps are low value items. Removing them would have no meaningful financial impact.
But the impact on animals would be enormous. Thousands of animals could be spared prolonged suffering and unlawful deaths.
Screenshot showing someone using glue traps bought from Amazon Uk to catch and kill mice, February 6th 2026.
Amazon UK has already faced scrutiny for failing to control the sale of harmful products. This is another moment where it must decide what kind of company it wants to be.
Will it continue to profit from animal cruelty it can see happening on its own platform?Or will it act?
We are calling on Amazon UK to do the right thing – stop the sale of glue traps to England, Wales and Scotland. Implement postcode restrictions. Remove these products from your platform.
And end this cruelty.
Now.
Adopt an Animal and support our work
By adopting an animal with Protect the Wild, you are directly supporting frontline campaigns that protect some of Britain’s most persecuted species. Our fox adoption symbolises our fight to finally end fox hunting for good. Our badger adoption represents our determination to stop the badger cull and protect wildlife from government-sanctioned killing. Our peregrine falcon adoption stands for our work exposing the bird shooting industry and defending birds of prey from persecution as we work to take that industry down.
RJ Hamster
One drug candidate, six viruses – NNVC makes its…
A message from Equiscreen
NNVC’s Broad-Spectrum Antiviral NV-387 Could Be the Hidden Biotech Titan Ready to Disrupt Multi-Billion-Dollar Viral Markets!
NanoViricides (NYSE: NNVC) is quietly emerging as a potential powerhouse in antiviral therapy with its lead candidate, NV-387. Unlike conventional antivirals that target viral proteins and risk losing effectiveness as viruses mutate, NV-387 mimics human cell surfaces to trap and neutralize viruses at the point of entry.
Its broad-spectrum capabilities extend across RSV, influenza, coronaviruses, measles, Mpox, and even smallpox — creating the possibility for a single therapy to address multiple urgent public health threats simultaneously.
With preclinical studies showing complete cures in lethal RSV models and superior results against influenza compared to standard antivirals, NV-387 is generating excitement among biotech insiders.
NNVC has just completed manufacturing NV-387 oral gummies and is gearing up for Phase II trials in the Democratic Republic of Congo for Mpox. Coupled with FDA Orphan Drug Designation filings for Mpox and measles, NNVC is strategically positioned to accelerate regulatory approval while benefiting from tax incentives, fee waivers, and market exclusivity.
With a potentially $20+ billion market within reach and clinical validation underway, this small-cap biotech could be a rare opportunity for outsized gains.
Friday’s Featured Story
Why Netflix Tanked Despite Big EPS Beat, Outlook Ahead
Reported by Leo Miller. Article Posted: 4/17/2026.
Key Points
- Netflix stock took a huge hit after its latest earnings report, even as EPS rose by over 80%
- A leftover from its failed WBD deal created a one-time earnings uplift
- Meanwhile, a key leader departed, and Netflix extended its live sports success internationally
- Special Report: This SpaceX IPO news Makes Me Furious (From The Oxford Club)
Entertainment giant Netflix (NASDAQ: NFLX) just released one of its more anticipated earnings reports in some time. The firm’s latest report is its first since losing the battle against Paramount Skydance (NASDAQ: PSKY) to acquire Warner Bros. Discovery (NASDAQ: WBD). To Netflix’s dismay, the market reacted negatively to the results. Understanding why requires looking beyond the headline numbers. Considering Netflix’s long-term growth drivers but underwhelming near-term guidance, the stock’s risk-reward setup appears relatively balanced.
Netflix’s Huge EPS Beat Doesn’t Tell the Full Story
In its Q4 fiscal 2025 (FY2025), Netflix posted revenue of $12.25 billion, up roughly 16% year-over-year (YOY). (Note that Netflix’s fiscal year reporting period is about one quarter ahead of the calendar period.) That topped expectations of $12.17 billion.
The REAL Reason Trump is Invading Iran (Ad)
For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.
The company reported an even larger bottom-line beat. Diluted earnings per share rose to $1.23, an 86% YOY increase and well above estimates of $0.76. However, that result was boosted by a key one-time item.
After losing the WBD deal, Paramount paid Netflix a $2.8 billion termination fee. That payout significantly increased Netflix’s net income and EPS. Excluding the one-time fee, EPS would have come in below expectations.
That distinction likely contributed to the firm’s nearly 10% drop in after-hours trading, as the breakup-fee benefit had already been disclosed.
Another headwind was Netflix’s softer-than-expected guidance for the next quarter. It forecast revenue of $12.57 billion, or growth of 13.5% YOY, slightly below estimates of $12.64 billion. The company also expects its operating margin to decline 150 basis points YOY to 32.6%—though that would be a 30 basis-point improvement versus Q4 FY2025.
Netflix left its full-year guidance unchanged at $50.7 billion to $51.7 billion (a $51.2 billion midpoint), just under consensus of $51.37 billion.
Hastings’s Departure Causes Jitters
Investors were also unsettled by the news that Reed Hastings will not stand for re-election to Netflix’s Board of Directors. Hastings co-founded Netflix in 1997 and served as CEO for 25 years. He is currently the company’s board chairman and will remain in that role until June, after which he plans to focus on philanthropy and other ventures. His departure raises questions about the future of Netflix’s board leadership.
On the earnings call, one analyst asked whether the pursuit of WBD influenced Hastings’s decision. Hastings has long favored a “build over buy” approach, preferring organic growth to acquisitions. If the WBD effort had driven his exit, it might signal a misalignment among top executives. Co-CEO Ted Sarandos pushed back, saying, “Reed was a big champion for that deal,” adding that the board unanimously supported it and that the decision had “absolutely nothing to do” with Hastings’s departure.
Still, the timing is notable: after pursuing one of the largest M&A deals in media history, Hastings is stepping away. Either way, his exit marks the end of an era for Netflix’s direct involvement from its longtime leader.
Live Sports and Ads: Critical Levers for Netflix’s Future Growth
Looking ahead, sustained growth will be key to NFLX’s ability to deliver long-term gains. Live sports are one of the most promising avenues. Netflix had success broadcasting the World Baseball Classic (WBC) during the quarter: the company said the WBC was its most-watched program ever in Japan and drove the largest single-day sign-ups on the platform in that market, with Japan leading Netflix’s total Q1 membership growth.
This success builds on massive viewership Netflix generated from broadcasting NFL games and the Mike Tyson vs. Jake Paul boxing match. The WBC was Netflix’s first major live event outside the United States, offering a playbook the company can replicate in U.S. and international markets to grow membership.
Netflix’s advertising push also appears on track. The company expects to double ad sales to $3 billion in 2026 and reported its advertiser base grew 70% YOY to 4,000 companies. As its advertiser base expands, Netflix should be able to improve ad targeting and generate more revenue per ad, since marketers will derive greater value from the platform over time.
This email communication is a sponsored message for Equiscreen, a third-party advertiser of MarketBeat. Why did I get this message?.
This message is a paid advertisement for Nanoviricides (NNVC) from Equiscreen and Interactive Offers. MarketBeat Media, LLC receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $14,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Equiscreen or Interactive Offers. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Nanoviricides (NNVC) on Interactive Offers’ website for additional information about the relationship between Interactive Offers and Nanoviricides (NNVC).
If you have questions about your subscription, please email MarketBeat’s South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl. #620, Sioux Falls, South Dakota 57103-7078. United States..
See Also: SpaceX gets new job from the Pentagon (Click to Opt-In)
RJ Hamster
One drug candidate, six viruses – NNVC makes its…
A message from Equiscreen
NNVC’s Broad-Spectrum Antiviral NV-387 Could Be the Hidden Biotech Titan Ready to Disrupt Multi-Billion-Dollar Viral Markets!
NanoViricides (NYSE: NNVC) is quietly emerging as a potential powerhouse in antiviral therapy with its lead candidate, NV-387. Unlike conventional antivirals that target viral proteins and risk losing effectiveness as viruses mutate, NV-387 mimics human cell surfaces to trap and neutralize viruses at the point of entry.
Its broad-spectrum capabilities extend across RSV, influenza, coronaviruses, measles, Mpox, and even smallpox — creating the possibility for a single therapy to address multiple urgent public health threats simultaneously.
With preclinical studies showing complete cures in lethal RSV models and superior results against influenza compared to standard antivirals, NV-387 is generating excitement among biotech insiders.
NNVC has just completed manufacturing NV-387 oral gummies and is gearing up for Phase II trials in the Democratic Republic of Congo for Mpox. Coupled with FDA Orphan Drug Designation filings for Mpox and measles, NNVC is strategically positioned to accelerate regulatory approval while benefiting from tax incentives, fee waivers, and market exclusivity.
With a potentially $20+ billion market within reach and clinical validation underway, this small-cap biotech could be a rare opportunity for outsized gains.
Friday’s Featured Story
Why Netflix Tanked Despite Big EPS Beat, Outlook Ahead
Reported by Leo Miller. Article Posted: 4/17/2026.
Key Points
- Netflix stock took a huge hit after its latest earnings report, even as EPS rose by over 80%
- A leftover from its failed WBD deal created a one-time earnings uplift
- Meanwhile, a key leader departed, and Netflix extended its live sports success internationally
- Special Report: This SpaceX IPO news Makes Me Furious (From The Oxford Club)
Entertainment giant Netflix (NASDAQ: NFLX) just released one of its more anticipated earnings reports in some time. The firm’s latest report is its first since losing the battle against Paramount Skydance (NASDAQ: PSKY) to acquire Warner Bros. Discovery (NASDAQ: WBD). To Netflix’s dismay, the market reacted negatively to the results. Understanding why requires looking beyond the headline numbers. Considering Netflix’s long-term growth drivers but underwhelming near-term guidance, the stock’s risk-reward setup appears relatively balanced.
Netflix’s Huge EPS Beat Doesn’t Tell the Full Story
In its Q4 fiscal 2025 (FY2025), Netflix posted revenue of $12.25 billion, up roughly 16% year-over-year (YOY). (Note that Netflix’s fiscal year reporting period is about one quarter ahead of the calendar period.) That topped expectations of $12.17 billion.
The REAL Reason Trump is Invading Iran (Ad)
For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.
The company reported an even larger bottom-line beat. Diluted earnings per share rose to $1.23, an 86% YOY increase and well above estimates of $0.76. However, that result was boosted by a key one-time item.
After losing the WBD deal, Paramount paid Netflix a $2.8 billion termination fee. That payout significantly increased Netflix’s net income and EPS. Excluding the one-time fee, EPS would have come in below expectations.
That distinction likely contributed to the firm’s nearly 10% drop in after-hours trading, as the breakup-fee benefit had already been disclosed.
Another headwind was Netflix’s softer-than-expected guidance for the next quarter. It forecast revenue of $12.57 billion, or growth of 13.5% YOY, slightly below estimates of $12.64 billion. The company also expects its operating margin to decline 150 basis points YOY to 32.6%—though that would be a 30 basis-point improvement versus Q4 FY2025.
Netflix left its full-year guidance unchanged at $50.7 billion to $51.7 billion (a $51.2 billion midpoint), just under consensus of $51.37 billion.
Hastings’s Departure Causes Jitters
Investors were also unsettled by the news that Reed Hastings will not stand for re-election to Netflix’s Board of Directors. Hastings co-founded Netflix in 1997 and served as CEO for 25 years. He is currently the company’s board chairman and will remain in that role until June, after which he plans to focus on philanthropy and other ventures. His departure raises questions about the future of Netflix’s board leadership.
On the earnings call, one analyst asked whether the pursuit of WBD influenced Hastings’s decision. Hastings has long favored a “build over buy” approach, preferring organic growth to acquisitions. If the WBD effort had driven his exit, it might signal a misalignment among top executives. Co-CEO Ted Sarandos pushed back, saying, “Reed was a big champion for that deal,” adding that the board unanimously supported it and that the decision had “absolutely nothing to do” with Hastings’s departure.
Still, the timing is notable: after pursuing one of the largest M&A deals in media history, Hastings is stepping away. Either way, his exit marks the end of an era for Netflix’s direct involvement from its longtime leader.
Live Sports and Ads: Critical Levers for Netflix’s Future Growth
Looking ahead, sustained growth will be key to NFLX’s ability to deliver long-term gains. Live sports are one of the most promising avenues. Netflix had success broadcasting the World Baseball Classic (WBC) during the quarter: the company said the WBC was its most-watched program ever in Japan and drove the largest single-day sign-ups on the platform in that market, with Japan leading Netflix’s total Q1 membership growth.
This success builds on massive viewership Netflix generated from broadcasting NFL games and the Mike Tyson vs. Jake Paul boxing match. The WBC was Netflix’s first major live event outside the United States, offering a playbook the company can replicate in U.S. and international markets to grow membership.
Netflix’s advertising push also appears on track. The company expects to double ad sales to $3 billion in 2026 and reported its advertiser base grew 70% YOY to 4,000 companies. As its advertiser base expands, Netflix should be able to improve ad targeting and generate more revenue per ad, since marketers will derive greater value from the platform over time.
This email communication is a sponsored message for Equiscreen, a third-party advertiser of MarketBeat. Why did I get this message?.
This message is a paid advertisement for Nanoviricides (NNVC) from Equiscreen and Interactive Offers. MarketBeat Media, LLC receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $14,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Equiscreen or Interactive Offers. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Nanoviricides (NNVC) on Interactive Offers’ website for additional information about the relationship between Interactive Offers and Nanoviricides (NNVC).
If you have questions about your subscription, please email MarketBeat’s South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl. #620, Sioux Falls, South Dakota 57103-7078. United States..
See Also: SpaceX gets new job from the Pentagon (Click to Opt-In)
RJ Hamster
One drug candidate, six viruses – NNVC makes its…
A message from Equiscreen
NNVC’s Broad-Spectrum Antiviral NV-387 Could Be the Hidden Biotech Titan Ready to Disrupt Multi-Billion-Dollar Viral Markets!
NanoViricides (NYSE: NNVC) is quietly emerging as a potential powerhouse in antiviral therapy with its lead candidate, NV-387. Unlike conventional antivirals that target viral proteins and risk losing effectiveness as viruses mutate, NV-387 mimics human cell surfaces to trap and neutralize viruses at the point of entry.
Its broad-spectrum capabilities extend across RSV, influenza, coronaviruses, measles, Mpox, and even smallpox — creating the possibility for a single therapy to address multiple urgent public health threats simultaneously.
With preclinical studies showing complete cures in lethal RSV models and superior results against influenza compared to standard antivirals, NV-387 is generating excitement among biotech insiders.
NNVC has just completed manufacturing NV-387 oral gummies and is gearing up for Phase II trials in the Democratic Republic of Congo for Mpox. Coupled with FDA Orphan Drug Designation filings for Mpox and measles, NNVC is strategically positioned to accelerate regulatory approval while benefiting from tax incentives, fee waivers, and market exclusivity.
With a potentially $20+ billion market within reach and clinical validation underway, this small-cap biotech could be a rare opportunity for outsized gains.
Friday’s Featured Story
Why Netflix Tanked Despite Big EPS Beat, Outlook Ahead
Reported by Leo Miller. Article Posted: 4/17/2026.
Key Points
- Netflix stock took a huge hit after its latest earnings report, even as EPS rose by over 80%
- A leftover from its failed WBD deal created a one-time earnings uplift
- Meanwhile, a key leader departed, and Netflix extended its live sports success internationally
- Special Report: This SpaceX IPO news Makes Me Furious (From The Oxford Club)
Entertainment giant Netflix (NASDAQ: NFLX) just released one of its more anticipated earnings reports in some time. The firm’s latest report is its first since losing the battle against Paramount Skydance (NASDAQ: PSKY) to acquire Warner Bros. Discovery (NASDAQ: WBD). To Netflix’s dismay, the market reacted negatively to the results. Understanding why requires looking beyond the headline numbers. Considering Netflix’s long-term growth drivers but underwhelming near-term guidance, the stock’s risk-reward setup appears relatively balanced.
Netflix’s Huge EPS Beat Doesn’t Tell the Full Story
In its Q4 fiscal 2025 (FY2025), Netflix posted revenue of $12.25 billion, up roughly 16% year-over-year (YOY). (Note that Netflix’s fiscal year reporting period is about one quarter ahead of the calendar period.) That topped expectations of $12.17 billion.
The REAL Reason Trump is Invading Iran (Ad)
For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason.Click here to find out what it is.
The company reported an even larger bottom-line beat. Diluted earnings per share rose to $1.23, an 86% YOY increase and well above estimates of $0.76. However, that result was boosted by a key one-time item.
After losing the WBD deal, Paramount paid Netflix a $2.8 billion termination fee. That payout significantly increased Netflix’s net income and EPS. Excluding the one-time fee, EPS would have come in below expectations.
That distinction likely contributed to the firm’s nearly 10% drop in after-hours trading, as the breakup-fee benefit had already been disclosed.
Another headwind was Netflix’s softer-than-expected guidance for the next quarter. It forecast revenue of $12.57 billion, or growth of 13.5% YOY, slightly below estimates of $12.64 billion. The company also expects its operating margin to decline 150 basis points YOY to 32.6%—though that would be a 30 basis-point improvement versus Q4 FY2025.
Netflix left its full-year guidance unchanged at $50.7 billion to $51.7 billion (a $51.2 billion midpoint), just under consensus of $51.37 billion.
Hastings’s Departure Causes Jitters
Investors were also unsettled by the news that Reed Hastings will not stand for re-election to Netflix’s Board of Directors. Hastings co-founded Netflix in 1997 and served as CEO for 25 years. He is currently the company’s board chairman and will remain in that role until June, after which he plans to focus on philanthropy and other ventures. His departure raises questions about the future of Netflix’s board leadership.
On the earnings call, one analyst asked whether the pursuit of WBD influenced Hastings’s decision. Hastings has long favored a “build over buy” approach, preferring organic growth to acquisitions. If the WBD effort had driven his exit, it might signal a misalignment among top executives. Co-CEO Ted Sarandos pushed back, saying, “Reed was a big champion for that deal,” adding that the board unanimously supported it and that the decision had “absolutely nothing to do” with Hastings’s departure.
Still, the timing is notable: after pursuing one of the largest M&A deals in media history, Hastings is stepping away. Either way, his exit marks the end of an era for Netflix’s direct involvement from its longtime leader.
Live Sports and Ads: Critical Levers for Netflix’s Future Growth
Looking ahead, sustained growth will be key to NFLX’s ability to deliver long-term gains. Live sports are one of the most promising avenues. Netflix had success broadcasting the World Baseball Classic (WBC) during the quarter: the company said the WBC was its most-watched program ever in Japan and drove the largest single-day sign-ups on the platform in that market, with Japan leading Netflix’s total Q1 membership growth.
This success builds on massive viewership Netflix generated from broadcasting NFL games and the Mike Tyson vs. Jake Paul boxing match. The WBC was Netflix’s first major live event outside the United States, offering a playbook the company can replicate in U.S. and international markets to grow membership.
Netflix’s advertising push also appears on track. The company expects to double ad sales to $3 billion in 2026 and reported its advertiser base grew 70% YOY to 4,000 companies. As its advertiser base expands, Netflix should be able to improve ad targeting and generate more revenue per ad, since marketers will derive greater value from the platform over time.
This email communication is a sponsored message for Equiscreen, a third-party advertiser of MarketBeat. Why did I get this message?.
This message is a paid advertisement for Nanoviricides (NNVC) from Equiscreen and Interactive Offers. MarketBeat Media, LLC receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $14,000. Other than the compensation received for this advertisement sent to subscribers, MarketBeat and its principals are not affiliated with either Equiscreen or Interactive Offers. MarketBeat and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither MarketBeat nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from MarketBeat to buy or sell any security. MarketBeat has not evaluated the accuracy of any claims made in this advertisement. MarketBeat recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Nanoviricides (NNVC) on Interactive Offers’ website for additional information about the relationship between Interactive Offers and Nanoviricides (NNVC).
If you have questions about your subscription, please email MarketBeat’s South Dakota based support team at contact@marketbeat.com.
If you would no longer like to receive promotional emails from MarketBeat advertisers, you can unsubscribe or manage your mailing preferences here.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 N Reid Pl. #620, Sioux Falls, South Dakota 57103-7078. United States..
See Also: SpaceX gets new job from the Pentagon (Click to Opt-In)
RJ Hamster
20 Years of Giving – UMPS CARE Charities auction…
Apr 17, 2026View OnlineFriday, April 17 at 10 a.m. EDT through Monday, April 27 at 10 p.m. EDT.
UMPS CARE Charities is the official philanthropy of the Major League Baseball Umpires, and part of the proceeds from this auction support their programs by providing:
• Furry friends, clothing and accessories from Build-A-Bear Workshop® to the bedside of children in hospitals in Major League markets
• College scholarships for young adults adopted later in life (13 years of age and older)
• VIP on-field baseball experiences with umpire meet and greets for youth-based organizations and military families
• Umpire skills and leadership training through a 6-week course that prepares teens with mentorship and employment on the field
• Financial Support for Sports Officials Care – a new non-profit inspiring and uniting the next generation of officials from the NFL, NBA, MLS, MLB and other professional leagues
Bid on signed baseballs, hats, jerseys, commemorative home plates, and more; awesome on-field baseball experiences, including a chance to be on the field to watch batting practice at Dodger Stadium, a special tour of the Hall of Fame in Cooperstown, and MLB All-Star Game and Home Run Derby tickets; MLB specialty game hats, and a plethora of miscellaneous items such as bobbleheads, jewelry, rounds of golf and stuff for kids!
Bid NowTo check your Watch List, access your Account, or update your info…
Log in to MLB Auctions
Don’t have an account?
Sign up here!© 2026 MLB Advanced Media, L.P. MLB trademarks and copyrights are used with permission of Major League Baseball. Visit MLB.com. Any other marks used herein are trademarks of their respective owners.
Please review our Privacy Policy.
You (peterhovis@icloud.com) received this message because you registered to receive commercial email messages from MLB Auctions.
Please add info@marketing.mlbemail.com to your address book to ensure our messages reach your inbox. If you no longer wish to receive commercial email messages from MLB Auctions, please unsubscribe or log in and manage your email subscriptions.
Postal Address: MLB Auctions, c/o MLB Advanced Media, L.P., 1271 Avenue of the Americas, New York, NY 10020.
RJ Hamster
Progress for Swifts at Chapel Milton Following Public Pressure
Forwarded this email? Subscribe here for more
Progress for Swifts at Chapel Milton Following Public Pressure
APR 17READ IN APP
There has been an important and encouraging development in the campaign to protect swift nesting sites at Chapel Milton viaduct in Derbyshire.
More than 12,800 people signed Protect the Wild’s petition calling on Network Rail to take action after known swift nesting holes were filled during refurbishment works earlier this year. That public response, alongside the tireless efforts of local campaigners on the ground, has clearly helped shift the situation.
A Positive Step Forward
In its initial response, Network Rail defended its actions and focused on installing swift boxes as a future measure.
However, in an email sent to Protect the Wild the other day, Network Rail confirmed it is now taking further steps. These include:
- Seeking permission to reopen nesting holes in the areas identified by campaigners
- Planning to install conservation-approved swift boxes
- Working with local authorities and conservation organisations including the RSPB and Swift Conservation
- Moving quickly to support a decision ahead of the swifts’ return
This is a significant step forward. Reopening nesting holes was not part of the original plan and is now being actively explored.
Why This Matters
Swifts are a red-listed species in the UK and have declined dramatically in recent decades, largely due to the loss of nesting habitat. They return each year to the same nesting sites, and when those sites are blocked, breeding can fail.
Reopening these nesting holes gives returning birds the best possible chance of breeding successfully this season.
While this is a positive development, the outcome is not yet confirmed.
Permission is still required, and the timing is critical as swifts begin to return from migration. The coming weeks will determine whether access can be restored in time.
What is clear, however, is that this issue has moved forward because people took action.
Thank You
This progress is down to the local campaigners who raised the alarm, gathered evidence, and refused to let this be ignored.
It is also down to the 12,800 people who signed Protect the Wild’s petition and helped turn concern into pressure.
That collective action has helped shift the response from defence to action.
We will continue to follow this closely and push for the best possible outcome for these birds.
For now, this is a reminder that when people come together and take action, it can make a real difference.LIKECOMMENTRESTACK